Email this article QUALITY OF LIFE AFTER HYSTERORESECTOSCOPY IN THE HYPERPLASTIC PROCESSES IN ENDOMETRIUM
- Authors: Trubitsyna M.V.1, Bakhtiyarov K.R1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 6, No 2 (2019)
- Pages: 103-106
- Section: Original study articles
- URL: https://journals.rcsi.science/2313-8726/article/view/43006
- DOI: https://doi.org/10.18821/2313-8726-2019-6-2-103-106
- ID: 43006
Cite item
Full Text
Abstract
The article is devoted to the assessment of the results of hysteroresectoscopy in hyperplastic processes in endometrium, namely, menstrual status, as well as such an important aspect as the quality of life of women after this treatment method. 52 patients with hyperplastic processes in the endometrium were examined, in all cases the effectiveness of hysteroresectoscopy in eliminating uterine bleeding, with the achievement of the maximum result, amenorrhea, was observed in 43 (82.69%) women. In all the subjects, a significant decrease in the quality of life and impaired sexual function were found, which significantly improved after surgery: energy 8.86 ± 2.92, pain 2.88 ± 0.83, sleep 6.65 ± 2.46, emotional reactions 6.02 ± 0.69, social isolation 3.23 ± 0.89, physical activity 4.55 ± 2.11; 22 (42.31%) - increased satisfaction; 9 (17.31%) - noted an increase in the frequency of sexual contacts.
Full Text
##article.viewOnOriginalSite##About the authors
Margarita V. Trubitsyna
I.M. Sechenov First Moscow State Medical University
Email: pumanikt@yandex.ru
student, I.M. Sechenov First Moscow State Medical University, 119991, Moscow, Russian Federation
K. R Bakhtiyarov
I.M. Sechenov First Moscow State Medical University119991, Moscow, Russian Federation
References
- Noventa M., Ancona E., Quaranta M., Vitagliano A., Cosmi E., D’Antona D. et al. Intrauterine morcellator devices: the icon of hysteroscopic future or merely a marketing image? A systematic review regarding safety, efficacy, advantages, and contraindications. Reprod. Sci. 2015; 22(10): 1289-96. doi: 10.1177/1933719115578929
- Garbin O., Schwartz L. New in hysteroscopy: hysteroscopic morcellators. Gynecol. Obstet. Fertil. 2014; 42(12): 872-6. doi: 10.1016/j.gyobfe.2014.10.002
- Barreix M., Barbour K., McCaw-Binns A., et al. Standardizing the measurement of maternal morbidity: Pilot study results. Int. J. Gynaecol. Obstet. 2018; 141 (Suppl. 1): 10-9. doi: 10.1002/ijgo.12464
- Federici S., Bracalenti M., Meloni F., Luciano J.V. World Health Organization Disability Assessment Schedule 2.0: An international systematic review. Disabil. Rehabil. 2017; 39: 2347-80.
- Kim A., Bradshaw H., Durante K.M., Hill S.E. Life history, fertility, and short-term mating motivation. Evol. Psychol. 2018; 16(3): 1-10. doi: 10.1177/1474704918800062.
- Mieras M. Sexual desire, the brain and our interoceptive consciousness. Ned. Tijdschr. Geneeskd. 2018;162. pii: D2758.
- Li C., Dai Z., Gong Y., Xie B., Wang B. A systematic review and meta-analysis of randomized controlled trials comparing hysteroscopic morcellation with resectoscopy for patients with endometrial lesions. Int. J. Gynaecol. Obstet. 2017; 136(1): 6-12. doi: 10.1002/ijgo.12012
- De Franciscis P., Grauso F., Cobellis L., Messalli E.M., Cucinella G., Perino A. et al. Outcomes of monopolar versus bipolar endometrial ablation on uterine bleeding and psychophysical wellbeing. Minerva Ginecol. 2017; 69(4): 328-35. doi: 10.23736/S0026-4784.16.03990-3
- Falcone F., Laurelli G., Losito S., Di Napoli M., Granata V., Greggi S. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J. Gynecol. Oncol. 2016; 28(1): e2. doi: 10.3802/jgo.2017.28.e2
- Багдасарян А.Р., Саркисов С.Э. Перфорация матки во время гистероскопии. Опухоли женской репродуктивной системы. 2014; (1): 85-90.
- Алекенова Н.У., Назарбаева Р.К., Кошербаева Л.К., Смагулова Г.А. Современные подходы и методы оценки качества жизни. Медицинский журнал Западного Казахстана. 2018; 57 (1): 23-7.
- Singh S., Darroch J.E., Ashford L.S. Adding It Up: The Costs and Benefits of Investing in Sexual and Reproductive Health 2014. New York: Guttmacher Institute; 2017
Supplementary files
